FDA NDC Directory · JSON-LD · Markdown

POSACONAZOLE

NDC 17856-2133 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Generic namePosaconazole
Labeler / ManufacturerATLANTIC BIOLOGICALS CORP.
Marketing categoryAbbreviated NDA (generic) · App ANDA212411
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsPOSACONAZOLE (100 mg/1)
Marketing started20190828
Package count2

External sources

Source: openFDA. Public-domain (CC0).